District Update January 30, 2023     


Dear ,

I hope you and your family are doing well! I wanted to provide a few updates on my work this past week for the residents of Arizona’s First Congressional District.

Debunking Myths on Republican Solutions to Save Social Security


Click here or on the image above to view my remarks.

Last week, I gave a speech on the House Floor debunking the myth that House Republicans want to cut Social Security and Medicare to balance the budget. That is simply not true. I talk about Social Security every day – it’s part of my job, and I have fought tooth and nail to ensure this program remains protected. In my 12 years in the House, I have never met a Republican Member of Congress talk about cutting Social Security. We need to quit playing politics with people’s livelihoods and focus on honest solutions that save retirement security.

An Update on Ways and Means Committee Organization

I am excited to announce that I will serve as Chairman of the Ways and Means Oversight Subcommittee for the 118th Congress. As Chairman of the Oversight Subcommittee responsible for overseeing the IRS, my top priority will be to serve as a voice for American taxpayers and advocate for common-sense reforms that put the American taxpayer first. Under my leadership, the Oversight Subcommittee will work with Medicare recipients and doctors to ensure that Medicare always puts patients and their physicians first.

Mobile Office Hours


Tomorrow, January 31st, my District Office team will be at the Granite Reef Senior Center located at 1700 N. Granite Reef, Scottsdale, AZ 85257, from 10 a.m. until 12 p.m. to assist constituents one-on-one with casework. If you, or someone you know, needs help with a federal benefit, such as Social Security, VA, or OPM, please come by to see how the office can be of service.

My office staff will also host mobile office hours on February 8th at the Saguaro Library located at 2808 N. 46th Street, Phoenix, AZ, 85008 from 3 p.m. until 5 p.m. If you are unavailable during these dates and times, or have any questions about casework or other constituent services, please call my district office at (480) 946-2411 for additional information or appointments. 

What I’m Reading & Why It Matters


Guardant Health, a leading precision oncology company, announced today that the U.S. Food and Drug Administration has approved its Guardant360® CDx liquid biopsy test as a companion diagnostic to identify advanced or metastatic breast cancer patients with ESR1 mutations who may benefit from treatment with ORSERDU™ (elacestrant), a nonsteroidal selective estrogen receptor degrader to be commercialized by Stemline Therapeutics, Inc., a wholly-owned subsidiary of Menarini Group.

The FDA approved Guardant360 CDx as a companion diagnostic (CDx) in conjunction with the approval of ORSERDU for postmenopausal women or adult men with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, ESR1-mutated, advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy.

This test will hopefully allow for more breakthrough treatments for metastatic breast cancer, which will in turn improve patients' prognosis as well as their quality of life. 

Thank you for taking the time to read this update on my latest work in Washington, D.C. and Arizona's First Congressional District! If you have any comments or concerns, I encourage you to reach out to my office.





David Schweikert